This is a temporary backup site for TRENDS MENA while our primary website is being restored following a regional disruption affecting Amazon Web Services cloud infrastructure in the GCC.

Search Site

Alujain widens 2025 loss

The increase in loss is due to impairment charges, weaker prices.

Masar 2025 net profit $262m

Higher land plot sales boost revenue and operating income.

Tasnee’s 2025 losses deepen

The petrochemicals' company's revenue also fell 17.7 percent.

DP World 2025 revenue $24.4bn

The profit for the year up 32.2% to reach $1.96bn.

BYD 2025 revenue surges

The EV manufacturer reported net profit of $.3.3bn for 9M 2025.

Estimated IVF market in UAE, KSA, Egypt about $1b

    • Colliers white paper explains why IVF popular in MENA region despite high population growth

    • IVF one of leading treatments undertaken by medical tourists in UAE

    In-vitro Fertilization (IVF) market in UAE, Saudi Arabia and Egypt is estimated to be worth $1 billion, according to a white paper on the IVF market in the Middle East.

    Global commercial real estate leader Colliers released the white paper whose focus is the UAE, Saudi Arabia and Egypt.

    The paper is the 14th edition in the “Puls Series” of research papers on healthcare in the MENA Region, which analyzes why IVF remains popular in the MENA region despite its having an overall high population growth rate.

    Mansoor Ahmad, director of health care, education, development solutions and PPP at Colliers (MENA region), said the current global IVF market is estimated to be between $10b and $13.7b.

    “Though there is no definitive accurate data available for the Middle East, the estimated IVF market size drawn from the number of cycles is roughly $200 million for the UAE, $300 million for KSA and $500 million for Egypt,” he said.

    The paper studies MENA’s IVF market, highlighting the cost of IVF treatments and explaining why markets such as Dubai, KSA and Egypt are considered “Hot Spots”. 

    It also highlights key insights for investors in the region as well as provides an outlook for the IVF market.

    “IVF is not only sought after locally but is one of the leading treatments undertaken by medical tourists in the UAE, especially in Dubai. On the other hand, KSA is also a growing market for IVF, with a plan to invest SR 250 billion ($66b) in healthcare infrastructure and boost private sector participation from current 40% to 65% by 2030,” Mansoor said.